Soliton – Consensus Indicates Potential 91.2% Upside

Broker Ratings

Soliton found using ticker (SOLY) have now 3 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 22 and 12 calculating the mean target price we have 16. With the stocks previous close at 8.37 this would imply there is a potential upside of 91.2%. The 50 day moving average now sits at 8.4 while the 200 day moving average is 8.22. The company has a market capitalisation of $177m. You can visit the company’s website by visiting:

Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits
Find more news, interviews, share price & company profile here for:

    Good news travels fast (but only if you make that happen). Share on:


      AIM All Share Index